Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear receptor subfamily 2 group E member 1 (NR2E1, also known as TLX) is an orphan nuclear receptor that functions primarily as a transcriptional repressor and regulator of gene expression in neural tissue. It plays a crucial role in maintaining the undifferentiated state and self-renewal capacity of adult neural stem cells, is essential for vision and proper retinal development, and helps pattern the anterior brain during embryogenesis. Dysregulation of NR2E1 disrupts neurogenesis, impairs vision, affects neural development, and can lead to behavioral abnormalities. Its activity appears to be modulated by specific ligands, including certain synthetic retinoids, and its molecular interactions—especially with corepressors—are structurally defined. NR2E1 is considered a high-value therapeutic target for diseases involving neural stem cell dysfunction or retinal pathology, though direct drug targeting remains in early research stages due to its role as an orphan nuclear receptor and the complexity of its functions
Transcriptional repression via corepressor recruitment (Atrophin corepressors binding via Atro box motif); Ligand-dependent modulation of transcriptional activity (certain synthetic and natural retinoids can influence activity); Regulation of downstream signaling pathways important for stem cell maintenance and differentiation
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear receptor subfamily 2 group E member 1 (NR2E1).